{"id":5711,"date":"2019-08-23T12:00:23","date_gmt":"2019-08-23T17:00:23","guid":{"rendered":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/?p=5711"},"modified":"2021-05-20T14:41:44","modified_gmt":"2021-05-20T19:41:44","slug":"interview-with-richard-zbaraschuk-dds","status":"publish","type":"post","link":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/2019\/08\/23\/interview-with-richard-zbaraschuk-dds\/","title":{"rendered":"Interview with Richard Zbaraschuk DDS"},"content":{"rendered":"

\"\"<\/a><\/p>\n

Dr. McGlennen:<\/strong> Tell me how you use OralDNA\u00ae salivary diagnostics.<\/p>\n

Richard Zbaraschuk, DDS:<\/strong> For each patient we utilize chairside microscopy. When I see mature biofilms and\/or Fn (Fusobacterium nucleatum), yeast, white blood cells (WBC), or spirochetes with the aid of the microscope, or the patient has consistent bleeding upon probing, I\u2019ll make the recommendation of OralDNA\u00ae testing.\u00a0 All new patients are given the MyPerioPath\u00ae brochure so they know all the options for testing that our office provides.\u00a0 Once I have results, I\u2019m able to better customize the treatment and protocols specific to the individual patient.<\/p>\n

Dr. McGlennen:<\/strong> What are the top two things to consider when you select a patient for testing?<\/p>\n

Richard Zbaraschuk, DDS:<\/strong> First, are there signs and symptoms of active periodontal disease, and secondly does the patient have any comorbidities that can play a role in how effective our treatment outcomes will be. I like to treat the whole patient, not just the mouth, so this modality of testing is ideal.<\/p>\n

Dr. McGlennen:<\/strong> What are the biggest benefits to using salivary diagnostics?<\/p>\n

Richard Zbaraschuk, DDS:<\/strong> We perform Alert 2\u2122 on almost every patient. This test includes MyPerioPath\u00ae, giving the patient a non-biased, reproducible lab test with a metric for further improvement on the bacterial profile. The MyPerioID\u00ae IL-6 portion of the Alert 2\u2122 lets us and patients be aware when we need to be more assertive with homecare and treatment, especially when the MyPerioID\u00ae IL-6 is reported as high risk or they have pathogens present that put them at risk for activity if their homecare or systemic health decreases.<\/p>\n

Dr. McGlennen:<\/strong> What is your favorite part of the MyPerioPath\u00ae results? Why?<\/p>\n

Richard Zbaraschuk, DDS:<\/strong> My favorite parts are the added systemic effects portion of the report, the color bar graph and graphics.\u00a0 It really does make an impact to the patients with the color system for the pathogens. I have not had a patient who reads about the pathogens and the systemic risks and does not want to follow through with treatment.<\/p>\n

Dr. McGlennen:<\/strong> How do your patients respond to this technology? What is their number one question?<\/p>\n

Richard Zbaraschuk, DDS:<\/strong> They respond well, especially as there is more media coverage out there about salivary testing and its uses for risk identification of other types of diseases.\u00a0 The question I get most often is regarding cost\/insurance coverage and regarding accuracy of the results.<\/p>\n

Dr. McGlennen:<\/strong> What is your biggest challenge? How do you overcome that obstacle?<\/p>\n

Richard Zbaraschuk, DDS:<\/strong> Cost is the big challenge.\u00a0 We overcome that by utilizing microscopy. When the patient can see what their biofilm looks like and watch organisms moving around on the screen, this makes a significant impact to testing and case acceptance.\u00a0 The other is talking about any other family history of chronic diseases and their risk factors with untreated periodontal disease. The value of knowing and making informed decisions about health empowers the patient to choose health.<\/p>\n

Dr. McGlennen:<\/strong> If a new OralDNA\u00ae provider were to ask you for advice, what would be your best tip?<\/p>\n

Richard Zbaraschuk, DDS:<\/strong> I would recommend that before talking with patients that the provider test the entire staff and make it a yearly part of their care.\u00a0 Once everyone accepts that the goal is to maintain health, not treat disease, it becomes easier to address with patients.\u00a0 Having your staff on-board is essential to acceptance.\u00a0 As a provider, I now rely on the test results, along with traditional clinical evaluations, to form my treatment plans and allow that metric to guide protocols.<\/p>\n

Dr. McGlennen:<\/strong> Where do you see salivary diagnostics in 3-5 years? 10 years? What would be the impact on your practice\/patients?<\/p>\n

Richard Zbaraschuk, DDS:<\/strong> The changes in the last 10 years in salivary diagnostics have been incredible.\u00a0 It is hard to imagine how more can be done.\u00a0 I would love to see point of contact results not only for the tests currently available but for screening and diagnostics for other chronic systemic diseases.\u00a0 There would be a greater impact to patients allowing them to be truly prevention oriented, maintaining and choosing health.<\/p>\n

For more information on how to become an OralDNA Provider \u2013 scan HERE:\u00a0\"\"<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

I would recommend that before talking with patients that the provider test the entire staff and make it a yearly part of their care. Once everyone accepts that the goal is to maintain health, not treat disease, it becomes easier to address with patients.<\/p>\n","protected":false},"author":82,"featured_media":5721,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[108,110],"tags":[112,3],"class_list":["post-5711","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-patient-education","category-salivary-diagnostics","tag-patient-education","tag-salivary-diagnostics"],"jetpack_featured_media_url":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/wp-content\/uploads\/2019\/08\/Zbar-Logo-Combo.png","jetpack_sharing_enabled":false,"jetpack_shortlink":"https:\/\/wp.me\/p7W16z-1u7","_links":{"self":[{"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/posts\/5711"}],"collection":[{"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/users\/82"}],"replies":[{"embeddable":true,"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/comments?post=5711"}],"version-history":[{"count":7,"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/posts\/5711\/revisions"}],"predecessor-version":[{"id":7715,"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/posts\/5711\/revisions\/7715"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/media\/5721"}],"wp:attachment":[{"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/media?parent=5711"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/categories?post=5711"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/wp-json\/wp\/v2\/tags?post=5711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}